Zhonghua Tong

693 citations
8 papers · 448 indexed · 2 hit papers · h-index 7

Zhonghua Tong

8 papers receiving 448 citations

Hit Papers

Protosappanin A Protects DOX‐Induced Myocar...54202220262023202450100150200250

Peers

Zhonghua Tong
Comparison fields: 5 of 67
  • Cancer Research 168
  • Molecular Biology 293
  • Immunology 80
  • Cardiology and Cardiovascular Medicine 61
  • Pulmonary and Respiratory Medicine 59
Replace Kristen Leslie with:
Kristen Leslie United States
Ge Mang China
Yiting Jia China
Yezhou Sun United States
Ping Sun China
Hao Qin China
Zulong Sheng China
Junlan Zhou China
Jin Gu Cho South Korea
Linjian Chen China
Zhonghua Tong relative to Kristen Leslie United States Kristen Leslie's profile →
Citations per field
00.5×11.8×
Kristen Leslie · 1×
Citations per year

Countries citing papers authored by Zhonghua Tong

Since Specialization
Citations

This map shows the geographic impact of Zhonghua Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghua Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghua Tong more than expected).

Fields of papers citing papers by Zhonghua Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghua Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghua Tong. The network helps show where Zhonghua Tong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhonghua Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhonghua Tong Line = papers co-authored together Zhonghua Tong links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 20247
2 202417
3 20245
4
Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosisbreakdown →
202454
5 20237
6
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarctionbreakdown →
2022291
7 202223
8 202044

About Zhonghua Tong

Zhonghua Tong is a scholar working on Transplantation, Cancer Research and Immunology, having authored 8 papers that have together received 448 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), Extracellular vesicles in disease (2 papers), Signaling Pathways in Disease (2 papers), RNA modifications and cancer (1 paper), Cardiac Fibrosis and Remodeling (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Phagocytosis and Immune Regulation (1 paper) and Cardiovascular Disease and Adiposity (1 paper). The work is most often cited by research in Cancer Research (168 citations), Molecular Biology (293 citations) and Immunology (80 citations). Zhonghua Tong has collaborated with scholars based in China. Frequent co-authors include Maomao Zhang, Naixin Wang, Qiannan Yang, Ge Mang, Dongni Wang, Jingxuan Cui, Xiangyu Yan, Xiaoqi Wang, Weiwei Wang and Mian Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Circulation Research and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026